Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity
NCT ID: NCT05343286
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
900 participants
INTERVENTIONAL
2022-04-29
2028-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training
NCT02142855
Sarcopenia Physical Activity and Metabolomic
NCT05199207
High-definition Surface Electromyography Markers for the Diagnosis and Monitoring of Sarcopenia
NCT06963359
Biomarkers of Sarcopenia and Frailty in Geriatric Patients
NCT05795556
Biological Aging of Skeletal Muscles in Humans
NCT02675192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objectives:
* Propose a support system through adapted and individualized physical activity, based on physical, biological and psycho-social indicators
* Identify the biological signatures (metabolomics, epigenetic) of muscle failure in the elderly.
Phenotype responders and non-responders in training
900 seniors (300 per group) APAP group: adapted and personalized physical activity APA group: adapted physical activity Control group: no physical activity
Total duration of the study 5 years, duration of participation for a patient 3 months; inclusion period: 57 months
Improvement of muscle failure in its broad definition (Strength, power, speed and lean mass)
) General data: description of characteristics with frequencies and percentage for categorical variables and with mean and standard deviation for quantitative variables.
ii) Analysis of the primary endpoint: Machine Learning (or supervised classification) and signaling pathway prediction approaches for statistical analysis and data interpretation.
iii) Analysis of secondary judgment criteria: approaches in Machine Learning (or supervised classification) and signaling pathway prediction for statistical analysis and interpretation of data with comparison of quantitative variables by Pearson correlation and categorical variables by t or chi 2 test depending on the case.
Adapt and individualize physical activity support for healthy or frail elderly people
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APAP group: adapted and personalized physical activity
12 weeks of adapted and personalized physical activity
blood sample
blood sample before and after 12 weeks of physical activity
physical assessement
physical assessement before and after 12 weeks of physical activity
* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition
psychometric assessment
Psychometric questionnaires
* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale
APA group: adapted physical activity
12 weeks of generic physical activity
blood sample
blood sample before and after 12 weeks of physical activity
physical assessement
physical assessement before and after 12 weeks of physical activity
* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition
psychometric assessment
Psychometric questionnaires
* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale
Control group: no physical activity
no physical activity
blood sample
blood sample before and after 12 weeks of physical activity
physical assessement
physical assessement before and after 12 weeks of physical activity
* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition
psychometric assessment
Psychometric questionnaires
* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample
blood sample before and after 12 weeks of physical activity
physical assessement
physical assessement before and after 12 weeks of physical activity
* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition
psychometric assessment
Psychometric questionnaires
* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated patient or beneficiary of a social security scheme
* Patient having signed a prior informed consent.
Exclusion Criteria
* Patients protected by law under guardianship or curatorship, or who cannot participate in a clinical study under Article L. 1121-16 of the French Public Health Code
* Presence of a physical or cognitive pathology preventing the performance of the adapted physical activity protocol over 3 months.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier GUERIN, PU-PH
Role: PRINCIPAL_INVESTIGATOR
geriatric Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-PP-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.